{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Breast Cancer: St. Gallen Meeting Endorses Multi-Gene Assays for Refining Chemo Decision","description":"Also from the Palm Beach Cancer Symposium, Kathy Albain, MD, talks  about the St. Gallen consensus meeting&amp;rsquo;s updated recommendations about adjuvant  therapy for breast cancer&amp;mdash;i.e., endorsing the 21-gene recurrence score and  70-gene profiling assay as key tools in decision-making for chemotherapy for  ER-positive disease.","author_name":"OT Broadcast News","author_url":"http:\/\/www.oncology-times.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/1109891\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/item\/1109891"}